American Century Companies’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Buy
146,804
+11,874
+9% +$135K ﹤0.01% 2143
2025
Q4
$1.1M Buy
134,930
+4,354
+3% +$50.1K ﹤0.01% 2285
2025
Q3
$1.57M Buy
130,576
+39,366
+43% +$414K ﹤0.01% 2159
2025
Q2
$926K Sell
91,210
-21,418
-19% -$144K ﹤0.01% 2321
2025
Q1
$628K Buy
112,628
+4,766
+4% +$41.7K ﹤0.01% 2421
2024
Q4
$870K Buy
107,862
+8,359
+8% +$76.7K ﹤0.01% 2309
2024
Q3
$1.02M Buy
99,503
+15,302
+18% +$151K ﹤0.01% 2225
2024
Q2
$595K Buy
84,201
+11,034
+15% +$98.8K ﹤0.01% 2377
2024
Q1
$1.01M Buy
73,167
+23,617
+48% +$280K ﹤0.01% 2151
2023
Q4
$456K Buy
49,550
+17,114
+53% +$124K ﹤0.01% 2396
2023
Q3
$196K Buy
32,436
+13,477
+71% +$110K ﹤0.01% 2597
2023
Q2
$147K Buy
+18,959
New +$108K ﹤0.01% 2602

Other funds holding ORIC

American Century Companies's ORIC Position: Q1 2026 in Review

American Century Companies increased its Oric Pharmaceuticals (ORIC) stake by 8.8% in Q1 2026, buying an estimated $135K and bringing the position to 146,804 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2143.

American Century Companies first reported a position in ORIC in Q2 2023 and has held it in 12 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • American Century Companies held 146,804 shares of Oric Pharmaceuticals worth $1.86M as of Q1 2026.
  • American Century Companies bought 11,874 Oric Pharmaceuticals shares in Q1 2026, an estimated $135K.
  • Oric Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2143 holding.
  • American Century Companies first reported a position in Oric Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.